New Key Statistics Module, Z-Score and F-Score
NAS:PRLD Key Ratios
| Market Cap $ M | 422.12 |
| Enterprise Value $ M | 359.88 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.54 |
| Price/Sales | 25.08 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 16.00 |
| EPS (TTM) $ | -1.00 |
| Beneish M-Score | -3 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 18.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.28 |
| EV-to-EBITDA | -4.36 |
| PEG | -- |
| Shares Outstanding M | 79.65 |
| Net Margin (%) | -465.30 |
| Operating Margin % | -503.21 |
| Pre-tax Margin (%) | -465.30 |
| Quick Ratio | 2.03 |
| Current Ratio | 2.03 |
| ROA % (ttm) | -63.57 |
| ROE % (ttm) | -106.17 |
| ROIC % (ttm) | -143.79 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.81 |
PRLD Number of Guru Trades
PRLD Volume of Guru Trades
Gurus Latest Trades with NAS:PRLD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PRLD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Prelude Therapeutics Inc Insider Transactions
No Available Data
News about NAS:PRLD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers